Passage Bio, Inc. (PASG) Tops Q2 EPS by 9c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.73), $0.09 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Here Group posts FY2026 results with $88M revenue, goodwill write-down
• Raymond James Starts Western Alliance Bancorporation (WAL) at Outperform